Mark A. Eckardt
Impact in
- Biotechnology top 1%
- Cancer Research and Treatments
-
- Sarcoma Diagnosis and Treatment
- Advanced Breast Cancer Therapies
Papers in
-
- Sarcoma Diagnosis and Treatment 22
- Renal cell carcinoma treatment 2
-
- Cancer Research and Treatments 8
- Co-authors
- Fritz C. Eilber (20 shared papers)Arun S. Singh (18 shared papers)Scott D. Nelson (16 shared papers)Sarah Dry (16 shared papers)Remi M. Ajiboye (3 shared papers)Jason Taizo Hamamoto (3 shared papers)Jeffrey C. Wang (3 shared papers)Nicholas Matthew Bernthal (6 shared papers)
- Journals
- Oncotarget (5 papers)Journal of Cellular Biochemistry (5 papers)Biochemical and Biophysical Research Communications (4 papers)Annals of Surgical Oncology (2 papers)Journal of Pediatric Hematology/Oncology (2 papers)
- Partner nations
- United StatesJapanThailand
In The Last Decade
Mark A. Eckardt
38 papers receiving 981 citations
Peers
Comparison fields: 5 of 60
- Biotechnology 284
- Pulmonary and Respiratory Medicine 386
- Oncology 106
- Cancer Research 55
- Biochemistry 25
Countries citing papers authored by Mark A. Eckardt
This map shows the geographic impact of Mark A. Eckardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Eckardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Eckardt more than expected).
Fields of papers citing papers by Mark A. Eckardt
This network shows the impact of papers produced by Mark A. Eckardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Eckardt. The network helps show where Mark A. Eckardt may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark A. Eckardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity. | 2013 | 93 |
| 2 | 2016 | 91 | |
| 3 | 2018 | 70 | |
| 4 | 2018 | 64 | |
| 5 | 2017 | 57 | |
| 6 | 2015 | 40 | |
| 7 | 2017 | 40 | |
| 8 | 2011 | 37 | |
| 9 | 2018 | 37 | |
| 10 | 2018 | 34 | |
| 11 | 2017 | 32 | |
| 12 | 2018 | 32 | |
| 13 | 2018 | 32 | |
| 14 | 2016 | 31 | |
| 15 | 2018 | 27 | |
| 16 | 2013 | 25 | |
| 17 | 2017 | 24 | |
| 18 | 2013 | 22 | |
| 19 | 2016 | 19 | |
| 20 | 2018 | 19 |
About Mark A. Eckardt
Mark A. Eckardt is a scholar working on Pulmonary and Respiratory Medicine, Biotechnology, Pathology and Forensic Medicine, Rheumatology and Neurology, having authored 41 papers that have together received 984 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (22 papers), Cancer Research and Treatments (8 papers), Spine and Intervertebral Disc Pathology (3 papers), Bone Tumor Diagnosis and Treatments (2 papers), Renal cell carcinoma treatment (2 papers), Neurofibromatosis and Schwannoma Cases (2 papers), Cancer, Hypoxia, and Metabolism (1 paper) and Toxin Mechanisms and Immunotoxins (1 paper). The work is most often cited by research in Biotechnology (284 citations), Pulmonary and Respiratory Medicine (386 citations), Oncology (106 citations), Cancer Research (55 citations) and Biochemistry (25 citations). Mark A. Eckardt has collaborated with scholars based in United States, Japan and Thailand. Frequent co-authors include Fritz C. Eilber, Arun S. Singh, Scott D. Nelson, Sarah Dry, Remi M. Ajiboye, Jason Taizo Hamamoto, Jeffrey C. Wang, Nicholas Matthew Bernthal, Kei Kawaguchi and Tasuku Kiyuna. Their work appears in journals such as Oncotarget, Journal of Cellular Biochemistry, Biochemical and Biophysical Research Communications, Annals of Surgical Oncology and Journal of Pediatric Hematology/Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.